Bridging gaps in cancer care: tackling social drivers of health to improve access and outcomes

Bridging gaps in cancer care: tackling social drivers of health to improve access and outcomes

How social factors impact care—and what you can do about it.

Access to cancer screenings and treatment isn’t equal. Factors like income, transportation, healthcare availability, and community resources can create barriers that delay care and worsen outcomes. Social drivers of health (SDOH) play a major role in these disparities—but how can organizations use data to address them effectively?

Join us for a practical discussion on how life sciences organizations can use real-world data to uncover hidden barriers, develop targeted interventions, and improve patient outcomes.

Of specific interested for: Real-world data/real-world evidence leaders
HEOR professionals in life sciences
Market access professionals in life sciences
Medical affairs
Commercial strategy teams​​​​​​​

                  Your details

        By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

        Terms & Conditions

        I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

         I agree for my registration data to be transferred to the sponsoring organization (Inovalon).

                  Subscribing to

Confirm sign-up

What you will learn:

How social factors impact care and access to innovative therapies
Key insights from real-world data and peer-reviewed research
Strategies for using data to target interventions and drive better health outcomes

Speakers:

Karl Kilgore, PhD
Director, Research Science and Advanced Analytics, Inovalon

Karl has over 30 years of experience in health economics, epidemiology, outcomes-based marketing, and disease registries. His expertise includes social drivers of health, risk adjustment, and real-world outcomes of novel therapies, particularly in oncology. At Inovalon, he leads the development of its social drivers of health data warehouse. Previously, he was Senior Research Scientist at Avalere Health and VP of Research at Cetus Group. Karl holds a PhD in Psychology from the University of Chicago, specializing in epidemiology, statistical analysis, research methods, and psychometrics.

Scott Bilder, PhD
Director, Research Science and Advanced Analytics, Inovalon

Scott leads comparative effectiveness, HEOR, performance improvement, and risk adjustment studies at Inovalon. His expertise spans health services research, pharmacoepidemiology, healthcare quality, and psychometrics, with a focus on insured youth and elderly populations. Previously, he held research and analytics leadership roles at IQVIA and Rutgers University, where he also taught statistics and research design. He was a market research manager at Lucent Technologies. Scott holds an AB in psychology from Albright College and an MS and PhD in applied statistics and psychometrics from Rutgers University.

Moderator:

Laura Dormer
Editor, The Evidence Base
Editor in Chief, Journal of Comparative Effectiveness Research
Editorial Director, Becaris Publishing

Share this webinar